More info
Novel potent, orally bioavailable, dual acetyl-CoA carboxylase (ACC1/ACC2) inhibitor, also being a substrate of the organic anion transporting polypeptides, leading to asymmetrical tissue distribution and increased concentrations in the liver relative to plasma and other tissues